Full-Time

Associate Scientist

Cell Culture

Posted on 4/17/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Compensation Overview

$58.5k - $97.5k/yr

+ Bonus

Entry, Junior

New City, NY, USA

Work Location Assignment: On Premise

Category
Lab & Research
Life Sciences
Required Skills
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • BA/BS in life science (e.g. biology, cell biology, immunology, virology, microbiology) with 0-2 years of experience
  • Hands-on experience with mammalian cells, aseptic technique, pipetting, microscopy, performing simple calculations, basic problem-solving
  • Proficiency in computer skills, including word processing, Excel, PowerPoint, and relevant scientific software
  • Strong attention to detail
  • Strong verbal and written communication
  • Ability to collaborate and work effectively in a team environment
Responsibilities
  • Perform mammalian cell culture, reagent preparation, and other assigned laboratory activities according to Standard Operating Procedures (SOPs)
  • Perform job responsibilities in compliance with GxP regulations
  • Maintain a detailed inventory of reagents and order laboratory supplies, as needed for daily laboratory operations
  • Review documentation associated with protocols and SOPs, including data archiving, data review
  • Collect and analyze data to support troubleshooting, qualification, and other lab projects. Present results at group meetings and project meetings. Write monthly progress report if applicable
  • Build team skills and collaborate effectively within the work group
  • Stay current on all departmental and corporate training
  • Follow procedures for assigned tasks and seek guidance when necessary
Desired Qualifications
  • Pharmaceutical and biotech drug discovery experience
  • Experience in flow cytometry
  • Experience in bioassays designed to assess antibody functionality

Pfizer develops and manufactures healthcare products, focusing on medicines and vaccines. The company conducts extensive research and development to create innovative treatments, which are then sold to governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and specialized medicines. A notable achievement is its partnership with BioNTech to create a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes accessibility by providing vaccines to underserved populations and continuously works on expanding its product offerings through new approvals and authorizations.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE